Skip to main content

Untuk trading di AS, kunjungi polymarket.us

icon for Kasus campak di AS pada tahun 2026?
Iklim & Sains·Pandemi

Kasus campak di AS pada tahun 2026?

icon for Kasus campak di AS pada tahun 2026?
Iklim & Sains·Pandemi

Kasus campak di AS pada tahun 2026?

Oct 1

Jan 1, 2027

Oct 1

Jan 1, 2027

Polymarket

$7,894,722 Vol.

Polymarket

$7,894,722 Vol.

↑3.5k

$15,502 Vol.

100%

↑4k

$240,759 Vol.

96%

↑4.5k

$2,485 Vol.

87%

↑4.75k

$568 Vol.

82%

↑5k

$241,133 Vol.

64%

↑7,5k

$193,280 Vol.

15%

↑10rb

$6,524,515 Vol.

7%

↑12,5rb

$356,524 Vol.

2%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, the U.S. has recorded 3,134 confirmed measles cases per CDC surveillance, already exceeding 2025’s full-year total of 2,289 and marking the highest annual count since 1991. Primary drivers include sustained outbreaks across 47 jurisdictions, with 95% of cases linked to 38 active or ongoing clusters and 94% occurring in unvaccinated or unknown-status individuals. Major activity centers in states such as South Carolina, Pennsylvania, and Utah, where transmission persists amid pockets of low MMR coverage. Official data distinguish confirmed cases from suspected reports, with 8% hospitalization rates and no verified 2026 deaths to date. Weekly CDC updates and state surveillance reports through year-end will refine final tallies, while vaccination trends and any new importations remain key variables.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,894,722
Tanggal Berakhir
Jan 1, 2027
Pasar Dibuka
Jun 30, 2026, 2:17 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, the U.S. has recorded 3,134 confirmed measles cases per CDC surveillance, already exceeding 2025’s full-year total of 2,289 and marking the highest annual count since 1991. Primary drivers include sustained outbreaks across 47 jurisdictions, with 95% of cases linked to 38 active or ongoing clusters and 94% occurring in unvaccinated or unknown-status individuals. Major activity centers in states such as South Carolina, Pennsylvania, and Utah, where transmission persists amid pockets of low MMR coverage. Official data distinguish confirmed cases from suspected reports, with 8% hospitalization rates and no verified 2026 deaths to date. Weekly CDC updates and state surveillance reports through year-end will refine final tallies, while vaccination trends and any new importations remain key variables.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,894,722
Tanggal Berakhir
Jan 1, 2027
Pasar Dibuka
Jun 30, 2026, 2:17 PM ET

Resolver

0x65070BE91...

Terkait

icon for Will there be at least 3200+ measles cases in the U.S. by September 30, 2026?

Will there be at least 3200+ measles cases in the U.S. by September 30, 2026?

99%
icon for Will South Sudan have an Ebola case in 2026?

Will South Sudan have an Ebola case in 2026?

68%
icon for New pandemic in 2026?

New pandemic in 2026?

6%

Hati-hati dengan link eksternal.

Pertanyaan yang Sering Diajukan

"Kasus campak di AS pada tahun 2026?" adalah pasar prediksi di Polymarket dengan 12 hasil yang mungkin di mana trader membeli dan menjual saham berdasarkan apa yang mereka yakini akan terjadi. Hasil terdepan saat ini adalah "↑3.5k" di 100%, diikuti oleh "↑500" di 100%. Harga mencerminkan probabilitas crowd-sourced real-time. Misalnya, saham yang dihargai 100¢ menyiratkan bahwa pasar secara kolektif memberikan peluang 100% pada hasil tersebut. Peluang ini bergeser terus-menerus saat trader bereaksi terhadap perkembangan dan informasi baru. Saham dengan hasil yang benar bisa ditukarkan seharga $1 setiap saham saat pasar diselesaikan.

Per hari ini, "Kasus campak di AS pada tahun 2026?" telah menghasilkan $7.9 million dalam total volume trading sejak pasar diluncurkan pada Dec 1, 2025. Tingkat aktivitas trading ini mencerminkan keterlibatan kuat dari komunitas Polymarket dan membantu memastikan bahwa peluang saat ini diinformasikan oleh kumpulan besar peserta pasar. Kamu bisa melacak pergerakan harga langsung dan trading di hasil apa pun langsung di halaman ini.

Untuk trading di "Kasus campak di AS pada tahun 2026?," jelajahi 12 hasil yang tersedia di halaman ini. Setiap hasil menampilkan harga saat ini yang mewakili probabilitas tersirat pasar. Untuk mengambil posisi, pilih hasil yang menurutmu paling mungkin, pilih "Ya" untuk mendukungnya atau "Tidak" untuk menentangnya, masukkan jumlahmu, dan klik "Trade." Jika hasil pilihanmu benar saat pasar diselesaikan, saham "Ya" kamu membayar $1 masing-masing. Jika salah, mereka membayar $0. Kamu juga bisa menjual sahammu kapan saja sebelum resolusi jika kamu ingin mengamankan keuntungan atau memotong kerugian.

Unggulan saat ini untuk "Kasus campak di AS pada tahun 2026?" adalah "↑3.5k" di 100%, yang berarti pasar memberikan peluang 100% pada hasil tersebut. Hasil terdekat berikutnya adalah "↑500" di 100%. Peluang ini diperbarui secara real-time saat trader membeli dan menjual saham, sehingga mencerminkan pandangan kolektif terbaru tentang apa yang paling mungkin terjadi. Cek kembali secara rutin atau tandai halaman ini untuk mengikuti bagaimana peluang bergeser saat informasi baru muncul.

Aturan resolusi untuk "Kasus campak di AS pada tahun 2026?" mendefinisikan dengan tepat apa yang harus terjadi agar setiap hasil dinyatakan sebagai pemenang — termasuk sumber data resmi yang digunakan untuk menentukan hasilnya. Kamu bisa meninjau kriteria resolusi lengkap di bagian "Aturan" di halaman ini di atas komentar. Kami menyarankan membaca aturan dengan cermat sebelum trading, karena mereka menentukan kondisi tepat, kasus khusus, dan sumber yang mengatur bagaimana pasar ini diselesaikan.